Allocations
United Flexible, (United Flexible), a portfolio company of Arlington Capital Partners, is to acquire Kreisler Manufacturing Corporation (Kreisler) for USD18.00 per share.
Headquartered in Elmwood Park, NJ, Kreisler is a manufacturer of precision metal components and assemblies for use in commercial and military aircraft engines as well as industrial gas turbines. The agreement to acquire Kreisler will further United Flexible’s strategy of becoming the preeminent designer and manufacturer of high pressure and high temperature gas and fluid conduits into mission critical systems for OEMs. The combined company will have approximately 700 employees.
John Devine, CEO of United Flexible, says: “With
Abac Solutions Manager has held the final closing of its maiden fund Abac Solutions (SCA) SICAR which targets mid-market investment opportunities in Spain.
The Fund closed after receiving capital from a well-balanced mix of institutions, including pension funds, endowments, financial institutions, fund of funds and family offices.
The Fund has had strong support from the investor community and has been able to attract a number of reputable global institutional investors, overcoming a challenging market environment to raise the largest first time fund in Southern Europe since the “Global Financial Crisis”. Of the capital raised, approximately 60% was committed from European
svt Group has acquired AIK Flammadur Brandschutz (AIK), a manufacturer of passive fire protection products and systems. Financial terms of the transaction have not been disclosed.
Established in Seevetal/Hamburg in 1969, svt is a leading passive fire protection and restoration management company in Germany. The Group operates in two segments – passive fire protection (“PFP”) and restoration management (“RM”), which share know-how and experience. svt has in total a network of 22 branches in Germany, local presence in Poland and Russia and a large international partner network.
IK Small Cap I Fund, advised by IK Investment Partners, is majority shareholder
Joolz, one of the fastest growing premium pushchair brands in the infant and juvenile industry, has received a minority investment from Gimv, a Belgium-based investment firm, to support the company’s further geographical expansion, both in Europe and abroad, as well as the launch of new products.
ROTH Capital Partners served as exclusive financial advisor to Joolz.
“ROTH did an extensive international search in Europe, the United States and Asia. Based on ROTH’s experience with fast growing consumer brands and in particular, those within the infant and juvenile sector, we were highly confident they would find the right partner for Joolz.
Forma Holdings (Forma), an international diversified cannabis company co-founded by Kingsley Capital Partners which operates in legalised, medicinal cannabis markets, has completed its first asset acquisitions and launched its second capital raise, targeting at least GBP10 million for expansion.
This follows the success of a fund raising earlier this year, the proceeds of which were used to acquire Forma’s initial US assets in the Southwestern United States.
This latest fund-raise will harness the rapidly growing interest in the US & Europe in the medical cannabis sector. Proceeds will be used to invest in growing the business and expanding in
Inflexion Private Equity has held the first and final close of Inflexion Enterprise Fund IV and Inflexion Supplemental Fund IV, securing commitments of GBP250 million for each new fund.
Raised exclusively from Inflexion’s existing LP base of blue chip investors from across Europe, the US and Asia, both funds reached their respective hard caps in a single closing, within just eight weeks of launch. In keeping with previous fundraisings, Inflexion closed on timetable and without the support of a placement agent.
Inflexion Enterprise Fund IV, the fourth generation of Inflexion funds focused on the UK lower mid-market, will follow
Funds advised by CVC Capital Partners (CVC) are to acquire 100 per cent of ÅR Packaging Group AB (AR Packaging) from Ahlstrom Capital and Accent Equity.
Founded in 2011 through the merger of A&R Carton and Flextrus, AR Packaging is one of Europe’s leading packaging companies with sales of approximately EUR560 million (pro forma 2015) and 2,200 employees across 17 factories in 9 countries. The company has performed strongly in recent years, posting a 27 per cent increase in net sales last year.
Headquartered in Lund, Sweden, the group is divided into three divisions: Branded Products, Barrier Packaging and Food
Baltic private equity house BaltCap has acquired a majority stake in the leading Estonian occupational health care company Qvalitas Arstikeskus AS (Qvalitas).
BaltCap Private Equity Fund II (BPEF II) signed an agreement to acquire 72 per cent of Qvalitas. The remaining 28 per cent are held by the management team. In addition to BPEF II, Erki Mölder, the CEO of Unimed Group is an investor in the holding company carrying out the transaction.
Qvalitas was founded in 1996 and it offers occupational heath care as well as general and specialised medical services in Estonia. The company is mainly known
The Standard Life European Private Equity Trust (SLEPET) has reported net asset value (NAV) total return for the six months to 31 March 2016 of 11.3 per cent. NAV total return for the 12 months to 31 March 2016 was 17.4 per cent.
The NAV at 31 March 2016 rose 10.2 per cent to 310.2p (30 September 2015; 281.6p) including the payment of a final dividend of 3.5p per ordinary share for the year ended 30 September 2015 in the period.
The Board has declared an interim dividend of 1.80p to be paid on 15 July 2016. It remains
Aleva Neurotherapeutics, a developer of next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, has raised USD 18 million in a Series C financing round.
The round was led by Greatbatch (NYSE:GB), a strategic lead investor contributing a total of USD5 million to the transaction. In February 2016, Aleva and Greatbatch announced the closing of a strategic development, supply and manufacturing agreement. In addition, Aleva will combine their innovative directional lead technology with the proprietary neurostimulation platform of Nuvectra, a recent spin-off from Greatbatch.
Aleva’s existing investors (BioMedPartners, BB Biotech Ventures,
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
